Prelude Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Prelude Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-420,413	Closed	-$4.17M	–	1506
2023 Q1	$4.17M	Buy	+420,413	New	+$4.16M	0.25%	81
2018 Q4	–	Sell	-600	Closed	-$4K	–	2270
2018 Q3	$4K	Buy	+600	New	+$4.66K	﹤0.01%	1649

Prelude Capital Management's APEN Position: Q2 2023 in Review

Prelude Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 420,413 shares — an estimated $4.17M sold.

Prelude Capital Management first reported a position in APEN in Q3 2018 and held it in 2 quarters. The position peaked at $4.17M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Prelude Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Prelude Capital Management sold 420,413 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $4.17M.
Prelude Capital Management first reported a position in Apollo Endosurgery, Inc. in Q3 2018 and held it in 2 quarters.
Prelude Capital Management's Apollo Endosurgery, Inc. position peaked at $4.17M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.